Please ensure Javascript is enabled for purposes of website accessibility Märkte und Analysen | BNY
at
de
intermediary
intermediary
false
true
Gathering data
Disclaimer Not Available

EINBLICKE

image
6 für 2026: Wesentliche Fragen für Investoren
BERICHTE | MAKRO INVESTMENTS

In unserem Outlook gehen Investitions- und Marktführer von BNY auf sechs zentrale Fragen ein, von denen wir glauben, dass sie das Jahr 2026 prägen werden.

Vantage Point: Rates, Rules and Reality Q1 2026
Berichte | Makroökonomisch

The BNY Investment Institute’s base case for the global economy this quarter is Recovery (40% probability), followed by Expansion (30% probability) and Slowdown (25% probability). Read the latest issue of Vantage Point, the team's quarterly economic analysis, for more.

Recalculating route
Berichte | Makroökonomisch

BNY's commitment to insight and perspectives comes to life through our investment and market leaders who gather quarterly to debate the key issues shaping markets today.

Are U.S. Equity Valuations Too Rich?
Artikel | Anleihen

With the S&P 500® hitting new highs, investors question if fundamentals or hype is fueling the rally. Despite uncertainty, the S&P 500 has delivered strong performance year to date. Its price-to-earnings (PE) ratio now sits at 22x above the nearly 17x long-term average. To some, that screams “overvalued,” but context matters.

Global Short-Dated High Yield: Why spreads don’t tell the whole story
Artikel | Anleihen

Cathy Braganza, senior portfolio manager at Insight Investment, explains why tightening spreads with high yields create a potentially attractive risk-return balance for credit investors.

Novo Nordisk: rethinking the playbook
Artikel | Aktien

Direct-to-client (DTC) health platforms and personalized compounded treatments may become standard practice in the rapidly evolving obesity treatment market. Walter Scott investment analyst Dr Oriana Beaumont believes that Novo Nordisk’s recent changes will help position them to effectively compete in this exciting and vast market.

Where next for central banks?
Artikel | Makroökonomisch

We sat down with Jason Granet, Chief Investment Officer at BNY, Vincent Reinhart, Chief Economist and Macro Strategist at BNY Investments Dreyfus and Mellon, and John Velis, FX and Macro Strategist for the Americas at BNY Markets, to discuss the direction of the U.S. economy, global central bank policy and the outlook for asset prices.

Assessing Europe's labelled bond market
IFMH | Anleihen

In this video, Fabien Collado, portfolio manager of the Responsible Horizons Euro Corporate Bond strategy, shares his thoughts on the evolution of labelled bonds in Europe and explains why robust due diligence is integral to spotting and validating opportunities

Why we’re overweight healthcare
IFMH | Aktien

In this video, BNY Investments Newton global income portfolio manager, Jon Bell discusses some of the reasons for overweighting healthcare despite the sector’s recent challenges.

Is the AI sector in a bubble?
IFMH | Aktien

In this video, BNY Investments Newton global income portfolio manager, Jon Bell assesses whether artificial intelligence (AI) is a bubble and outlines some potential ways to diversify exposure to the large tech players in the space.

Gathering data
Disclaimer Not Available

Dies ist eine Marketingkommunikation